Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

Empower Clinics $CBDT.ca and EuroLife Brands $EURO.ca Close Definitive Agreement and Sign Multi-Year Multi-National Licence Agreement $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:13 AM on Friday, May 15th, 2020
  • Empower Clinics to power online education platform for patients, retail locations, national tele-medicine platform and their expanding network of franchisees with EuroLife’s Cannvas.me
  • Under the terms of the agreement, Empower has been granted an exclusive license of the Cannvas.me platform in the United States and Mexico with an option to expand to other jurisdictions

VANCOUVER, BC / May 15th, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated life sciences company, is pleased to announce that further to the letter of intent announced on February 25, 2020 it has signed a definitive agreement with EuroLife Brands (“EuroLife”), a vertically integrated enterprise focused on the pan-European hemp, cannabinoid, and health and wellness sector. The agreement grants Empower an exclusive license to EuroLife’s “Cannvas.me” cloud based online educational platform in certain international jurisdictions. Empower will use the web-based education technology platform to deliver brand, product, and industry knowledge to employees and over 165,000 patients across Empower’s six corporate clinics in Arizona, Oregon, its first franchise in Oklahoma and nationwide tele-health platform.

Under the terms of the agreement, Empower has been granted an exclusive license of the Cannvas.me platform in the United States and Mexico with an option to expand to other jurisdictions. The agreement includes a three-year term with a three-year renewable option. A licensing fee will be paid over the life of the agreement, consisting of a mixture of cash and stock totalling $460,000 CAD and includes comprehensive service level agreements from EuroLife and ongoing support from EuroLife team roles including VP of Technology, Senior Developer, Quality Assurance, Creative Designer, Program Management, Account Management and regular support from EuroLife’s CEO.

“We needed a robust platform to reach our growing network of owned and franchised locations across the United States and EuroLife’s Cannvas.me education platform exceeds all of our requirements,” said Steven McAuley, chairman and chief executive officer of Empower. “We now have the ability to reach our employees and the patients they serve through a safe, secure and informative online education portal. I believe the ability to deliver consistent product education quickly and efficiently is a competitive advantage that we will leverage as we continue to grow our patient count and number of locations.”

“I am very pleased to announce the agreement with Empower to license our Cannvas.me education portal to reach both employees and medical and retail consumers on an incredibly efficient basis,” said Shawn Moniz, Chief Executive Officer, EuroLife Brands Inc. “I look forward to working with Steven and his incredible team at Empower as they expand their footprint across the United States.”

Cannvas.me is a consumer education portal launched in 2018 for medical and recreational cannabis consumers. Through many discussions with industry stakeholders the management team discovered there was significant demand for a cloud-based education portal for licensed producers, retail dispensaries and other large to mid-sized companies in the cannabis sector.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The Company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company now offers COVID-19 testing options in the United States and physician-based consultations, to address COVID-19 concerns.

About EuroLife Brands Inc.

EuroLife Brands is a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein

SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws.All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding: the Company’s expected timing of filing of its Annual Filings, the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond; the ability of the Company to complete or execute phases One, Two, Three or Four of COVID-19 test programs, and Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , ,
Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca and EuroLife Brands $EURO.ca Close Definitive Agreement and Sign Multi-Year Multi-National Licence Agreement $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Baby Meals Growing by 153% as Parents Stock Up on Infant Nutrition – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 5:46 PM on Thursday, May 14th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY)The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q2 2020 with International agreements in Q3. Learn More

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Baby Meals Growing by 153% as Parents Stock Up on Infant Nutrition

  • The COVID-19 outbreak caused many consumers to stock up on essentials as they feared an indefinite lockdown
  • Baby food is one essential item that has seen soaring demand during the pandemic

Many consumers have struggled to find items like canned or jarred baby foods and infant formula in stores and online as manufacturers like Similac and Enfamil work to increase their production and restock shelves.

There has also been rising demand for organic baby foods as consumers are more concerned about ensuring their children have access to healthy foods that can help boost their personal immunity. All of this has led to a rising interest in baby meal delivery services like Yumi and Little Spoon which provide a weekly menu of freshly prepared meals suitable for babies and toddlers.

Read More: https://www.researchandmarkets.com/issues/baby-meals-growing-by-153pct?utm_source=dynamic&utm_medium=GNOM&utm_code=4bbmhbutm_campaign=1385666+-+Baby+Food+Sees+Soaring+Demand+During+COVID-19+Pandemic&utm_exec=joca220gnomd

Tags: , , ,
Posted in All Recent Posts, Else Nutrition Holdings Inc., Featured | Comments Off on Baby Meals Growing by 153% as Parents Stock Up on Infant Nutrition – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

Could #COVID19 be telehealth’s big moment? #Mhealth – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:27 AM on Thursday, May 14th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Could COVID-19 be telehealth’s big moment?

  • Over the five-year period that the analysis looks at, the U.S. telehealth market could see a compound annual growth rate (CAGR) of 38.2%
  • This year alone, the analysts expect the market to experience year-over-year growth of 64.3%

By Sean Whooley

Frost & Sullivan announced today that recent analysis finds that the demand for telehealth technology is expected to rise amid the COVID-19 pandemic.

The analysis, titled “Telehealth — A Technology-Based Weapon in the War Against the Coronavirus, 2020,” revealed that, as COVID-19 continues to disrupt the practice of medicine and the delivery of healthcare, the U.S. telehealth market will experience seven-fold growth by 2025.

Over the five-year period that the analysis looks at, the U.S. telehealth market could see a compound annual growth rate (CAGR) of 38.2%. This year alone, the analysts expect the market to experience year-over-year growth of 64.3%.

“The critical need for social distancing among physicians and patients will drive unprecedented demand for telehealth, which involves the use of communication systems and networks to enable either a synchronous or asynchronous session between the patient and provider,” Frost & Sullivan healthcare principal analyst Victor Camlek said in a news release. “However, all stakeholders need to remember that many people use the terms ‘telehealth’ or ‘telemedicine’ without understanding the ecosystem that is involved. This study will clarify the many components that are needed in order to implement telehealth.”

Camlek said that virtual visits and remote patient monitoring will propel the telehealth market, then mHealth and personal emergency response systems will come into play as well.

The analysis hypothesizes that the opportunity for telehealth to become the standard of care is growing amid the pandemic and the main challenge for providers is the capabilities for scaling up during the increase in demand.

Frost & Sullivan expects growth to be sustained beyond the pandemic by vendors who deliver user-friendly sensors, practical applications of artificial intelligence, interactive virtual assistants and robotics, as well as use of big data analytics and adherence to cybersecurity, among other things.

Source: https://www.medicaldesignandoutsourcing.com/could-covid-19-be-telehealths-big-moment/

Tags: , , , , , , ,
Posted in All Recent Posts, CardioComm Solutions | Comments Off on Could #COVID19 be telehealth’s big moment? #Mhealth – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

How Does #AI and ML Help In Up-scaling #Edtech? – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 11:18 AM on Thursday, May 14th, 2020

SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. betterU / Ottolearn launch FREE COVID-19 mobile resource toolkit to fight the global crisis – Click here for more information.

  • Online test preparations is also one of the growing segments in the Indian Ed tech space, almost 70 percent of traditional publishers are digitising their content since they see a sizeable addressable market
  • Students are looking for technology-driven, flexible and convenient options for themselves and these factors are gradually making the prospect of higher education online more appealing for students and professionals.

By Gairika Mitra

India is known as one of the best education markets globally. However, education in India comprises of high costs especially related to textbooks as one is never enough. The founders saw a market opportunity as students restrict their intelligence and score by accessing a limited number of course books simply because it is not affordable and possible to buy all the books available physically.

Thus, KopyKitab helps students whether in school, college or competitive exams aspirants to access the top-selling syllabus digitally through their library. The AI and ML programs also help students access relevant books for their needs.

Amit Shrivastava, Co-founder & CTO, KopyKitab tells us why depending on technology in the education space is a good idea.

The current pandemic has left many topsy turvy. Has this lockdown led to an upsurge in traffic?

Ed tech today has spread its wings far and wide; for KopyKitab, we are growing fast and have seen 69% rise in new users, a 45% increase in reading session and 200% jump in revenue. As students and institutions get more comfortable using Ed tech services and virtual classrooms, they are not shying away from paying for relevant content. We believe that Ed tech has shown the potential to disrupt the entire value chain.

Online test preparations is also one of the growing segments in the Indian Ed tech space, almost 70 percent of traditional publishers are digitising their content since they see a sizeable addressable market. Students are looking for technology-driven, flexible and convenient options for themselves and these factors are gradually making the prospect of higher education online more appealing for students and professionals.

How are you abiding by a different business model, especially when there are plenty of other players in the market?

For KopyKitab, since its inception, we have set out to make education more affordable and accessible. From the day when Ed tech was yet to go through a technological disruption and textbooks especially Higher Education, costs a lot, and students, especially from Tier II and Tier III towns, had limited access, we understood the pain points from our own experience as both the founders have grown up in small towns and did their schooling. At that time, due to lack of technology, getting study books access was a task as compared to our peers in Tier I and Metros. The KopyKitab model is aimed at making education a level playing field for students anywhere in India

We have mastered the content acquisition and distribution, and adopted a mobile-first strategy and have managed to recreate an offline studying experience for students online, at a much lower cost, our focus areas are into higher education and competitive exams sector and we are already very near to creating a niche for ourselves.

As students need everything quickly on the go, KopyKitab is exactly giving them that, bite-sized learning on their mobiles.

How areAI and ML contributing to your cause?

At KopyKitab, we are using Artificial Intelligence & Machine Learning programs that help track users consumption patterns and make more accurate recommendations based on language, city, campus, grade level, renting history, etc. It also helps us identify specific student’s needs

AI and ML programs have helped us increase the reach even in the remotest areas. Since, about 68 percent of our users hail from Tier II and III towns, with maximum demand coming from Patna, Jaipur, and Indore; five percent are overseas users, while the remaining comes from metros and Tier-I cities

The most critical and latest technology which we started catering in the COVID-19 pandemic is P2P (Peer to Peer) with structured learning options & Video Connectivity, be it teacher to students, coach to the students & content publishers to students, which is creating a highly optimised beneficial learning environment

Also, this will continue to be the base for all the tech platforms since it provides digital connection between people

How important do you think is it for people to rely on technology? Are there any major follies per se?

The future will undoubtedly be technology-driven, as stakeholders in the education ecosystem look to make access easier and provide flexibility in the learning environment. All this while keeping in mind that social distancing will be the norm going forward, technology will be the front runner for this connection be it WFH, P2P, Group connect as mentioned above

One of the major follies per se will be the absence or scarcity of direct human connect leading to longer time for execution for all the verticals

Could you acquaint us with your funding scenario?

In 2018, KopyKitab was backed by ECF, a Rs 100 crore fund registered under the SEBI. The fund’s marquee investors include Michael and Susan Dell Foundation and Gray Matters Capital, both US-based international investors in the education sector.

KopyKitab has also raised about $2 million from Pactolus Singapore, CBA Capital (ECF) and well-known angels including Praveen Gandhi, Paula Mariwala (Stanford Angels), Mohit Dubey (Carwale), Satyen Kothari (Citrus Pay), and others

What are KopyKitab’s upcoming plans like?

Our immediate priority would be to continue to serve our subscribers i.e students with more content in easy and engaging forms. We saw a surge in our traffic since the lockdown started in Mar and our aim to serve them with the best learning options.

For longer-term, providing P2P and Video-based access for our students, teachers/coaches and publishers to continue education without much interference because of the current scenario.

A piece of advice for others?

My advice would be to think long term solutions in digital/online space and if possible convert part of your business to digital/internet driven. Also, provide more accessibility between employees and customers using technology as base.

Source: https://www.expresscomputer.in/news/how-does-ai-and-ml-help-in-up-scaling-edtech/55638/

Tags: , , , , , ,
Posted in betterU Education Corp | Comments Off on How Does #AI and ML Help In Up-scaling #Edtech? – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Mota Ventures $MOTA.ca Signs Letter of Intent to Acquire German Leader in Psilocybin Space with a 110,000 Square Foot Manufacturing Facility $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 7:49 AM on Thursday, May 14th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

VANCOUVER, BC / ACCESSWIRE / May 14, 2020 /Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC PINK:PEMTF) (the “Company“) announces that it has entered into a letter of intent (the “Letter of Intent“), dated May 11, 2020, with Verrian Ontario Ltd. (“Verrian“), pursuant to which the parties intend to evaluate a potential transaction involving the acquisition of all of the outstanding share capital of Verrian (the “Proposed Transaction“). Verrian is an arms’-length privately-held company that is focused on delivering and developing products related to addiction reduction, with a focus on alcohol and opiates.

ESTABLISHED EUROPEAN PSYCHEDELIC MEDICINE COMPANY

Verrian owns and operates an EU-GMP, ISO 14001 compliant 110,000 sq. ft. pharmaceutical manufacturing facility in Radebuel, Germany. Verrian purchased the facility from a major global pharmaceutical manufacturer in 2019. Both the facility and equipment are independently appraised at Cdn$10,600,000, including an analytical laboratory, and full pharmaceutical manufacturing suite.

Operations within this full suite pharmaceutical manufacturing site include analytical laboratory and finished dose manufacturing, which exceed all international quality standards.

Verrian is composed of three distinct business segments:

  • Pharmaceutical Manufacturing – A portfolio of medical & wellness products
  • Phyto API – API creation from medical plants
  • Analytical Testing – European Medicine Agency Standards

PRODUCTS FOCUSED ON OPIATE ADDICTION REDUCTION

Verrian’s singular focus is rewiring the mind to overcome addiction through natural medicine. Specifically, the micro dosing of psilocybin demonstrates potential to remove the dopamine reward of addictive substances, potentially diminishing the desire for addictive substances, thereby reducing or eliminating the need for the addictive substance.

To date Verrian has developed:

  • PSI GEN and
  • PSI GEN+

These Psilocybin products are focused on opiate addiction reduction. As Natural Psilocybin extracts, from organically cultivated mushrooms, combined with metabolism enhancing natural herbs, they are ideal for individuals commencing micro-dosing and capable of being combined with additional anti-addiction therapies.

All of Verrian’s compounds are derived from organic, glyphosate free naturally occurring plants, grown specifically for its own purposes.

GOALS AND VISION

In addition to facility & equipment investments outlined above, the company has invested Cdn$2,400,000 worth of clinical trial design development and proprietary formulations into its psilocybin trademarked PSI-GEN formulations, and cannabis products, including trademarked CBDaily and CBNight.

Verrian’s world renowned addiction medicine experts are moving ahead to develop new potential treatments for therapy, with rigorous clinical research. Once EU GMP & narcotics handling recertification are secured, capabilities will extend to:

  • Specialty Pharma – Custom formulations
  • Psilocybin Refinement & Production – For micro dosing

“I am extremely excited at the opportunity to acquire an established Psychedelic medicine company in Europe. As an innovative company, Mota always seeks to be a leader in the natural health space and we see the psychedelic medicine market becoming a major part of the industry. This acquisition allows us to have first mover advantage in the Psychedelic market, and Mota’s existing distribution network will be ready to capitalize on the opportunity once regulation has been put in place,” stated Ryan Hoggan, CEO of the Company.

The Letter of Intent contemplates that the Company would acquire all of the outstanding share capital of Verrian in consideration for Cdn$21,100,000, of which Cdn$20,000,000 will be satisfied through the issuance of common shares (the “Consideration Shares“) to the existing shareholders of Verrian, and the balance will be payable in cash to retire certain outstanding shareholder loans due and owing by Verrian. The Consideration Shares will be subject to the terms of a thirty-six month time release pooling arrangement, during which time they may not be transferred, assigned, pledged or otherwise traded.

Readers are cautioned that the Letter of Intent entered into with Verrian does not set forth the final terms of the Proposed Transaction, nor have such terms been finalized. Any consideration offered to acquire Verrian remains subject to the results of ongoing due diligence. Completion of the Proposed Transaction is subject to a number of conditions, including, not limited to, completion of due diligence, negotiation of definitive documentation, and the receipt of any required regulatory approvals. The Proposed Transaction cannot be completed until these conditions are satisfied and there can be no assurance that the Proposed Transaction will be completed at all.

The Proposed Transaction is not expected to constitute a fundamental change for the Company, nor is it expected to result in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. The Company will provide further information regarding its review of Verrian, and the Proposed Transaction, as that information becomes available.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its Nature’s Exclusive brand. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Tags: , , , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Signs Letter of Intent to Acquire German Leader in Psilocybin Space with a 110,000 Square Foot Manufacturing Facility $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Hollister Biosciences Inc. $HOLL.ca CEO Provides Corporate Update $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 9:27 PM on Wednesday, May 13th, 2020
  • “As the country begins to emerge from stay at home orders, we thought it would be prudent to provide our shareholders with an update on our operations and some additional details on our recently announced acquisitions, Alphamind and Venom Extracts.” Said Carl Saling, CEO Hollister. “Integration of the new companies is well underway and continues to run smoothly”

VANCOUVER, May 13, 2020  - Hollister Biosciences Inc. (CSE: HOLL, OTC: HSTRF,  FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to provide a Corporate Update from CEO, Carl Saling.

“As the country begins to emerge from stay at home orders, we thought it would be prudent to provide our shareholders with an update on our operations and some additional details on our recently announced acquisitions, Alphamind and Venom Extracts.” Said Carl Saling, CEO Hollister. “Integration of the new companies is well underway and continues to run smoothly”

COVID-19 (the “Pandemic”) Update

In many states across the country cannabis was deemed an essential business and Hollister has been able to stay operational in all the states in which it operates.

It has been a challenging environment; however, we have navigated the new environment effectively.  Some cities and counties only allowed curbside pick-up and or delivery of cannabis, while others have closed but others stayed completely open for business using and implementing safety precautions.

Hollister took action to help the communities in which they operate by manufacturing hand sanitizer and donated it to offices and front-line workers. As recognition for our efforts the county of Hollister, California awarded Hollister Cannabis Co. a Certificate of Appreciation for our support.

Today, Hollister’s facilities are operating under social distancing guidelines to ensure the Company’s employees are safe.  The Company has also provided employees with gloves, masks and hand sanitizer to take home.  It is the Company’s first order concern during the pandemic to ensure that employees are operating in a safe and healthy environment and provide them with the tools they need to keep themselves and their families safe.

Hollister Cannabis Co.

Hashbone, the Company’s bubble hash infused pre roll brand, continues to grow and gain new fans daily.  The Company introduced HashBone “Minis” which are 0.5 gram bubble hash infused pre-rolls packaged in a 5 pack. The Company has rolled out Hybrid and Sativa SKU’s now available in select California dispensaries. 

The Company also plans to introduce the HashBone “Wolfie”, which answers the call of the true connoisseur. The HashBone Wolfie is a traditional HashBone coated with full spectrum cannabis oil and rolled in bubble hash.  There is hash on the inside and hash on the outside with full spectrum oil holding them together.  The HashBone Wolfie is currently in the testing phase and estimated to be in the market before the end of May 2020. 

Strategic Alliances with Tommy Chong

Further to the news release dated February 7, 2020, the Company is pleased to disclose the strategic relationship with Tommy Chong is progressing well. Hollister is very close to launching its 1st SKU with Tommy Chong called Tommy Chong’s Cannabis Full Spectrum Elixir comprising a 1:1 ratio – 500mg CBD: 500mg THC.  The product has completed testing, labels are being generated, and the Company expects product launch before the end of May 2020.

Venom Extracts

Venom Extracts (“Venom“) continues to be integrated within Hollister Biosciences operations and the synergies are evident. Plans are underway for expansion of Venom into Hollister’s manufacturing facility in California with engineering and permitting processes underway.  The Company anticipates Venom will be producing in California in Q4 2020.

Throughout the pandemic, Venom products continued to see significant growth in demand which resulted in record revenue for Q1, 2020.  Although these numbers will be disclosed in Hollister’s Q1 report, only a small portion will be included in Hollister’s audited financial statements, as the acquisition closed on March 24, 2020 

AlphaMind

The integration process is underway pursuant to the Company’s recently announced acquisition of AlphaMind (see News release dated April 30, 2020).  The Company believes AlphaMind’s medicinal mushroom based product SKU’s will be complementary to Hollister’s existing product line.  AlphaMind has an agreement in place with an established US based manufacturing partner.  It is the Company’s intention to build out an e-commerce platform to market and distribute AlphaMind’s product line.  AlphaMind is a new entrant in the burgeoning medicinal mushroom sector and is also in the process of developing IP surrounding psilocybin based pharmaceutical treatments.

Future Objectives

The Company believes the pandemic has changed consumer behaviour, possibly in a permanent fashion. 

Hollister believes it can capitalize on this in several ways:

  • The company is looking to accelerate its direct to consumer platform for both the hemp and the cannabis markets.
  • Hollister Biosciences will look to build a centralized ecommerce management system that will streamline the sales and marketing of all Hollister Biosciences non cannabis brands like Rebel Hemp Company & AlphaMind.
  • The Company will continue to evaluate the changing cannabis regulatory landscape to expand operations into new states.
  • The Company will also evaluate new technologies which may be utilized in the Company’s Facilities in the future.
  • Hollister Cannabis Co. is currently in the design phase of expanding its facility to accommodate the Venom brand.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Tags: , , , , ,
Posted in Hollister Biosciences | Comments Off on Hollister Biosciences Inc. $HOLL.ca CEO Provides Corporate Update $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

CLIENT FEATURE: Hollister $HOLL.ca A Vertically Integrated Cannabis Co With Products In 220 California Dispensaries , JVs & Partnerships With Global Brands $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 4:49 PM on Wednesday, May 13th, 2020

Hollister Highlights Of Current Operations:

  • Hollister’s products are now present in 220 of 600 California dispensaries.
  • Own’s California’s #1 hash infused pre-roll “HashBone”
  • Vision is to capitalize on this success to become the sought after premium brand portfolio of Cannabis across multiple states and Hemp nationwide
  • Major LOI, Joint Ventures and Licensing Agreements Support Proof Of This Vision
  • “Easy Riders” – Milliions Of Global Followers
  • “Tactical Relief” – Veteran Founded, Hemp Based CBD Brand With Nation Wide Members  
  • “Tommy Chong” – Exclusive Manufacture & Distribution Of Tommy Chong’s Cannabis (TM) Full Spectrum Elixir 1:1

“I only partner with the best-in-class companies and I am really pleased to have the Hollister Cannabis Co. bring their amazing Tommy Chong’s Cannabis™ Full Spectrum Elixir to the market for me”. 

– Tommy Chong

2 Highly Accretive Acquisitions

Hollister Biosciences Closes Transformational Acquisition of Rapidly Growing Venom Extracts Adding Over $16.4 Million In 2019 Revenue and $2.5 Million in EBITDA

  • one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.

HIGHLY ACCRETIVE $20,000,000 ACQUISITION, ADDING OVER CDN$16.4 MILLION OF 2019 REVENUE

  • For the year ended December 31, 2019, management of Venom Extracts reports having generated over CDN$16.4 million in revenue and over CDN$2.5 million in EBITDA from its product line of cannabis concentrates and cartridges. 
  • Venom Extract’s management also reports a strong start to 2020 and is anticipating record Q1 revenue.

Hollister Biosciences Closes Acquisition of AlphaMind Brands Inc.

  • Alphamind Brands is developing a portfolio of certified legal mushroom based natural health products
  • The company’s “ready to ship” product SKU’s include Cordyceps, Lion’s Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate.

FULL DISCLOSURE: Hollister Biosciences Inc. is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Hollister Biosciences | Comments Off on CLIENT FEATURE: Hollister $HOLL.ca A Vertically Integrated Cannabis Co With Products In 220 California Dispensaries , JVs & Partnerships With Global Brands $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

TransCanna $TCAN.ca Takes Major Step Towards Delivery License $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:14 AM on Wednesday, May 13th, 2020
TransCanna (@TransCanna) | Twitter
  • Lyfted Farms, has recently executed a lease on property in Lemoore, California that has received approval for a ‘rezoning’ to ‘Industrial’
  • Zoning designation makes the facility eligible for cannabis delivery, along with distribution, manufacturing, and cultivation activities following the anticipated approval of a Conditional Use Permit and Development Agreement, applications for which are currently being finalized
  • Creating this subsidiary with a focus on delivery, says Blink, is also part of the companies’ strategy to service customers in the current environment and at a time when consumer behaviors are affected by potential store closures and safety measures aimed at avoiding the spread of the coronavirus

Vancouver, British Columbia–(May 13, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Lyfted Farms, has recently executed a lease on property in Lemoore, California that has received approval for a ‘rezoning’ to ‘Industrial.’ The newly approved ‘Industrial’ zoning designation makes the facility eligible for cannabis delivery, along with distribution, manufacturing, and cultivation activities following the anticipated approval of a Conditional Use Permit and Development Agreement, applications for which are currently being finalized.

The company has also filed entity registration documents with the California Secretary of State under the name Lyfted Farmacy Inc., to create a new subsidiary with the intention of this business unit being dedicated to delivery. By doing so, TransCanna gains another important business component to complete the supply chain from grow operations to delivery in the California cannabis market (the largest legal market in the world), which is projected to expand exponentially.

“The city of Lemoore has been a great partner to work with. They have been highly responsive and professional partners, especially in this first step towards setting up a fully operational distribution and delivery hub,” says Bob Blink, TransCanna CEO. “The city has really opened their door to Lyfted Farms and been welcoming of our business.”

Creating this subsidiary with a focus on delivery, says Blink, is also part of the companies’ strategy to service customers in the current environment and at a time when consumer behaviors are affected by potential store closures and safety measures aimed at avoiding the spread of the coronavirus.

“We wanted to make sure that we could get higher-quality products from our facility to our customer’s doors in a safe manner,” says Blink. “Having come from diverse industries and bringing this breadth of knowledge to TransCanna means that our management team will continue looking for opportunities to remain highly responsive to changing market demands, and our customers evolving needs.”

This announcement follows news by the company released last week reporting the companies’ quarterly results and record monthly revenue earnings, and a recent announcement that renowned cannabis and lifestyle brand, Cookies, will carry Lyfted Farms products in select locations.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , ,
Posted in TransCanna Holdings Inc. | Comments Off on TransCanna $TCAN.ca Takes Major Step Towards Delivery License $CGC $ACB $APH $CRON.ca $OGI.ca

CLIENT FEATURE: Tartisan #Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes of 0.62% Nickel + 0.33% Copper – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 6:12 PM on Tuesday, May 12th, 2020
Tc logo in black

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  copper credits
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

Recent News

  • Company has completed a Spectral Analysis Survey
  • Survey covered the patented and single-cell mining claims that make up the historic land position which contains the Kenbridge Deposit and the surrounding area, identifying several new exploration targets not only for nickel, copper, cobalt, but also for potential gold occurrences
  • Analysis Survey shows the distribution and intensity of up to 304 minerals, with the first pass showing up to 16 minerals
  • Each mineral can be classified into an exploration relevance for base metals, precious metals and industrial metals

Tartisan CEO Mark Appleby said, “the survey picked out the Kenbridge Deposit, and has shown the possible extension to the Kenbridge Deposit and three additional trends that relate directly to underlying geology and structure implicit in the Kenbridge Deposit. Of significant interest, the survey found two gold trends as well, which include the Violet and Nina historic gold occurrences. One of the occurrences is almost 54 hectares in size and covers almost all of three of our staked claims on the border of the Kenbridge property.”

Industry News

INDUSTRY BULLETIN: Cobalt price, nickel usage limit damage to EV Metal Index

INDUSTRY BULLETIN: Nickel prices jump after Vale trims output target

INDUSTRY BULLETIN: Nickel prices get a boost from pandemic-driven ore supply tightness

INDUSTRY BULLETIN: Have the next crop of battery metals producers been oversold?

FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

Tags: , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Tartisan Nickel | Comments Off on CLIENT FEATURE: Tartisan #Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes of 0.62% Nickel + 0.33% Copper – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

How #Facebook is using #AI to combat #COVID19 misinformation and detect ‘hateful memes’ – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:46 PM on Tuesday, May 12th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

How Facebook is using AI to combat COVID-19 misinformation and detect ‘hateful memes’

By Nick Statt

Facebook on Monday released a new report detailing how it uses a combination of artificial intelligence and human fact-checkers and moderators to enforce its community standards. The report — called the Community Standards Enforcement Report, which usually encompasses data and findings from the prior three to six months — has a large focus on AI this time around.

That’s because Facebook is relying more on the technology to help moderate its platform during the COVID-19 pandemic, which is preventing the company from using its usual third-party moderator firms because those firms’ employees are not allowed to access sensitive Facebook data from home computers.

That said, Facebook says the data it’s compiled so far doesn’t contain any larger trends in its enforcement or in offending behavior on its platform because the pandemic hit so late in its reporting period. “This report includes data only through March 2020 so it does not reflect the full impact of the changes we made during the pandemic,” writes Guy Rosen, the company’s vice president of integrity, in a blog post. “We anticipate we’ll see the impact of those changes in our next report, and possibly beyond, and we will be transparent about them.’

Given the state of the world, Facebook’s report does contain new information about how the company is specifically combating coronavirus-related misinformation and other forms of platform abuse, like price gouging on Facebook Marketplace, using its AI tools. Facebook put warning labels on 50 million coronavirus-related posts last month

“During the month of April, we put warning labels on about 50 million posts related to COVID-19 on Facebook, based on around 7,500 articles by our independent fact-checking partners,” the company said in a separate blog post, penned by a group of its research scientists and software engineers, about its ongoing COVID-19 misinformation efforts published today. “Since March 1st, we’ve removed more than 2.5 million pieces of content for the sale of masks, hand sanitizers, surface disinfecting wipes and COVID-19 test kits. But these are difficult challenges, and our tools are far from perfect. Furthermore, the adversarial nature of these challenges means the work will never be done.”

Facebook says its labels are working: 95 percent of the time, someone who is warned that a piece of content contains misinformation will decide not to view it anyway. But producing those labels across its enormous platform is proving to be a challenge. For one, Facebook is discovering that a fair amount of misinformation as well as hate speech is now showing up in images and videos, not just text or article links.

“We have found that a substantial percentage of hate speech on Facebook globally occurs in photos or videos,” the company says in a separate hate speech-specific blog post about its recent moderation findings and research. “As with other content, hate speech also can be multimodal: A meme might use text and image together to attack a particular group of people, for example.”

This is a tougher challenge for AI to tackle, the company admits. Not only do AI-trained models have a harder time parsing a meme image or a video due to complexities like wordplay and language differences, but that software must also then be trained to find duplicates or only marginally modified versions of that content as it spreads across Facebook. But this is precisely what Facebook says it’s achieved with what it calls SimSearchNet, a multiyear effort across many divisions within the company to train an AI model how to recognize both copies of the original image and those that are near-duplicates and have perhaps one word in the line of text changed. “We have found that a substantial percentage of hate speech on Facebook globally occurs in photos or videos.”

“Once independent fact-checkers have determined that an image contains misleading or false claims about coronavirus, SimSearchNet, as part of our end-to-end image indexing and matching system, is able to recognize near-duplicate matches so we can apply warning labels,” the company says. “This system runs on every image uploaded to Instagram and Facebook and checks against task-specific human-curated databases. This accounts for billions of images being checked per day, including against databases set up to detect COVID-19 misinformation.”

Facebook uses the example of a misleading image modeled after a broadcast news graphic with a line of overlaid text reading, “COVID-19 is found in toilet paper.” The image is from a known peddler of fake news called Now8News, and the graphic has since been debunked by Snopes and other fact-checking organizations. But Facebook says it had to train its AI to differentiate between the original image and a modified one that says, “COVID-19 isn’t found in toilet paper.”

The goal is to help reduce the spread of duplicate images while also not inadvertently labeling genuine posts or those that don’t meet the bar for misinformation. This is a big problem on Facebook where many politically motivated pages and organizations or those that simply feed off partisan outrage will take photographs, screenshots, and other images and alter them to change their meaning. An AI model that knows the difference and can label one as misinformation and the other as genuine is a meaningful step forward, especially when it can then do the same to any duplicate or near-duplicate content in the future without roping in non-offending images in the process.

Source: https://www.theverge.com/2020/5/12/21254960/facebook-ai-moderation-covid-19-coronavirus-hateful-memes-hate-speech

Tags: , , , , ,
Posted in Datametrex AI Limited | Comments Off on How #Facebook is using #AI to combat #COVID19 misinformation and detect ‘hateful memes’ – SPONSOR: Datametrex AI Limited $DM.ca

« Older Entries
Newer Entries »